Collaboration

#Chiesi #Collaboration #Karolinska Institutet #Research and development

Collaboration to make therapeutic solutions to health challenges

Chiesi Group has signed a memorandum of understanding with Karolinska Institutet (KI) to collaborate on joint efforts aimed accelerating research and development initiatives for respiratory diseases, rare diseases, diseases of prematurity, and other speciality care indications. Chiesi Group and KI will exchange ideas, expertise, and resources… Read More

#News

#AI #Cancer research #Collaboration #Drug development #Lantern Pharma #Metabolic inhibitor #Oregon Therapeutics #Protein disulfide isomerase (PDI)

AI collaboration to optimise development of cancer inhibitor drug 

Lantern Pharma has entered a strategic AI-driven collaboration with French biotechnology company Oregon Therapeutics to optimise the development of its first-in-class protein disulfide isomerase (PDI)1 inhibitor drug candidate XCE853 in novel and targeted cancer indications.   Lantern will be leveraging its RADR AI platform to uncover biomarkers and efficacy-associated signatures of XCE853 across solid… Read More

#Business & Investment #Cancer Research #News

Respiratory system
#Collaboration #Evotec #Fibrosis #Variant Bio

Evotec and Variant Bio partner to develop fibrosis treatments

Evotec and Variant Bio have announced a collaboration agreement to identify a best-in-class treatment for diseases caused by fibrosis. Despite the chronic nature of fibrotic conditions, widespread impact on various organs, and substantial disease burden, there is currently no curative treatment for these conditions. The strategic partnership will combine Variant… Read More

#Business & Investment #News

#Cell and gene therapy #Cell therapy #Collaboration #Manufacturing #Partnership

Partnership to speed up cell therapy delivery

Autolomous and BioCentriq have collaborated to digitise and accelerate process development and manufacturing activities for cell therapy. Autolomous’ software platform is designed to materially affect the cell and gene therapy sector. BioCentriq will leverage the autoloMATE platform to streamline its process development operations and enhance client experience. This partnership aims… Read More

#Business & Investment #News

#Bios Health Group #Biotech #Biotech hubs #Collaboration #Life science #Start-ups

Bios launches biotech hub to support life science progress

Bios Health Group has launched the Bios Innovation Circle – a new venture studio and strategic hub, designed to support biotechnology and life science companies towards growing success. The Bios Innovation Circle is a venture studio and strategic hub designed to catalyse the growth of start-ups,… Read More

#News #Start-up Zone

#Collaboration #Contract Research Organisations (CROs) #Informatics #Partnership

Webinar: Effectively manage collaborations in drug discovery

Join DDW and Revvity Signals for this free event ‘Enhancing collaboration between sponsors and contract partners in drug discovery’. The event will take place on 23 April at 4pm BST / 5pm CEST / 11am EDT / 8am PDT. Most contemporary… Read More

#News

#Collaboration #Contract Research Organisations (CROs) #Informatics #Partnership

Webinar: Enhance collaborations with contract partners

Join DDW and Revvity Signals for this free event ‘Enhancing collaboration between sponsors and contract partners in drug discovery’. The event will take place on 23 April at 4pm BST / 5pm CEST / 11am EDT / 8am PDT. Most contemporary… Read More

#News

Blood cells
#Biotechnology #Collaboration #Funding #Haematology #Hemostatics

Validating a revolutionary therapy against lethal haemorrhage 

A public-private consortium formed by the biotech Hemostatics, based at the Barcelona Science Park, the Clínica Universidad de Navarra (CUN) and the Institute of Chemical Research of Catalonia (ICIQ), has received €2.5 million from the Spanish Research Agency (AEI), under the call for grants for Public-Private Collaboration Projects, to… Read More

#News

Biochemists working in the lab
#Amyotrophic lateral sclerosis (ALS) #Collaboration #Motor neurone disease #Oligonucleotides #PrecisionLife

R&D partnership to jointly develop new ALS drugs

PrecisionLife and the Nucleic Acid Therapy Accelerator (NATA) have announced a collaboration to co-develop novel oligonucleotide therapies for sporadic motor neurone disease/ALS. The collaboration combines NATA’s expertise in NAT design and optimisation with PrecisionLife’s understanding of complex disease biology and the mechanisms, drug targets and treatments… Read More

#News

#Collaboration #Contract Research Organisations (CROs) #Informatics #Partnership

Webinar: Enhancing collaboration in drug discovery

Join DDW and Revvity Signals for this free event ‘Enhancing collaboration between sponsors and contract partners in drug discovery’. The event will take place on 23 April at 4pm BST / 5pm CEST / 11am EDT / 8am PDT. Most contemporary… Read More

#News

#Collaboration #Contract Research Organisations (CROs) #Informatics

Enhancing collaboration between sponsors and contract partners in drug discovery

Most contemporary drug discovery companies (sponsors) outsource some (or all) drug development to external contract partners, eg. Contract Research Organisations (CROs) and/or Contract Development and Manufacturing Organisations (CDMOs). Communication between sponsor and contract organisation is largely done via email and poorly structured Excel reports which is a highly manual, inefficient,… Read More

Webinar date:
Brought to you by Revvity Signals
#Webinars

A team working in a laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Last chance to register: Enhancing collaboration in drug discovery

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

#Collaboration #Contract Research Organisations (CROs) #Informatics #Partnership

Webinar: Overcome the challenges of outsourcing in drug development

Join DDW and Revvity Signals for this free event ‘Enhancing collaboration between sponsors and contract partners in drug discovery’. The event will take place on 23 April at 4pm BST / 5pm CEST / 11am EDT / 8am PDT. Most contemporary… Read More

#News

#Collaboration #Drug development #Drug discovery #Partnership

Six March 2024 deals advancing drug discovery

Allogene Therapeutics and Arbor Biotechnologies Biotechnology companies Allogene Therapeutics and Arbor Biotechnologies entered a non-exclusive, global gene editing licensing agreement for use of Arbor’s proprietary CRISPR gene-editing technology in Allogene’s AlloCAR T platform for the treatment of autoimmune disease (AID). “The potential for CAR T as… Read More

#News

Research laboratory
#Biotech #Collaboration #Contract Research Organisations (CROs) #Drug discovery #Torx Software

Webinar: Enhancing collaboration in drug discovery

Join DDW and Cresset for this free event ‘Enhancing collaboration in drug discovery – a biotech perspective’. The event will take place on 28 March at 2pm GMT / 3pm CET / 9am EST / 6am PST. Delivery of synthesis targets… Read More

#News

#Bruntwood SciTech #Collaboration #Life sciences #R&D #Thermo Fisher Scientific

National collaboration to support life science sector 

Bruntwood SciTech and Thermo Fisher Scientific have entered into a new strategic collaboration to support businesses across Bruntwood SciTech’s national portfolio of life science campuses, with a particular focus at their Alderley Park campus in Cheshire – the UK’s largest single site life science campus, which is home to… Read More

#News